These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10691539)

  • 1. Sickle cell anemia therapy: progress since Pauling.
    Schechter AN; Rodgers GP
    Science; 2000 Jan; 287(5453):592-3. PubMed ID: 10691539
    [No Abstract]   [Full Text] [Related]  

  • 2. The therapeutic reactivation of fetal haemoglobin.
    Olivieri NF; Weatherall DJ
    Hum Mol Genet; 1998; 7(10):1655-8. PubMed ID: 9735388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid and augmentation of fetal hemoglobin in individuals with and without sickle cell disease.
    Selby R; Nisbet-Brown E; Basran RK; Chang L; Olivieri NF
    Blood; 1997 Jul; 90(2):891-3. PubMed ID: 9226193
    [No Abstract]   [Full Text] [Related]  

  • 4. The increasing complexity of sickle cell anemia.
    Warth JA; Rucknagel DL
    Prog Hematol; 1983; 13():25-47. PubMed ID: 6199811
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in the understanding of sickle cell anemia.
    Charache S
    Hosp Pract (Off Ed); 1986 Feb; 21(2):173-8, 182-90. PubMed ID: 2419352
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating sickle cell anemia.
    Tisdale JF; Thein SL; Eaton WA
    Science; 2020 Mar; 367(6483):1198-1199. PubMed ID: 32165573
    [No Abstract]   [Full Text] [Related]  

  • 7. The therapy of sickle-cell anemia.
    Lehmann H
    Prog Clin Biol Res; 1979; 34():361-8. PubMed ID: 531061
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 9. Fetal haemoglobin induction in sickle cell disease.
    Paikari A; Sheehan VA
    Br J Haematol; 2018 Jan; 180(2):189-200. PubMed ID: 29143315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapatient variability in fetal hemoglobin measurements over time in sickle cell patients not on fetal hemoglobin inducing agents.
    Knapp E; Cohen H; Kutlar A; Ghalie R; Manwani D
    Am J Hematol; 2016 Mar; 91(3):E11-2. PubMed ID: 26661045
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic Therapies for Sickle Cell Disease.
    Jayavaradhan R; Malik P
    Pediatr Clin North Am; 2018 Jun; 65(3):465-480. PubMed ID: 29803277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea for sickle cell anemia.
    Naina HV; Harris S
    N Engl J Med; 2008 Jul; 359(1):98; author reply 98-9. PubMed ID: 18596283
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment Options for Sickle Cell Disease.
    Meier ER
    Pediatr Clin North Am; 2018 Jun; 65(3):427-443. PubMed ID: 29803275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxyurea, sickle cell disease and renal transplantation.
    Allen A; Scoble J; Snowden S; Hambley H; Bellingham A
    Nephron; 1997; 75(1):106-7. PubMed ID: 9031282
    [No Abstract]   [Full Text] [Related]  

  • 15. Should we still be focused on red cell hemoglobin F as the principal explanation for the salutary effect of hydroxyurea in sickle cell disease?
    Segel GB; Simon W; Lichtman MA
    Pediatr Blood Cancer; 2011 Jul; 57(1):8-9. PubMed ID: 21480473
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of sickle cell disease.
    Steinberg MH
    N Engl J Med; 1999 Apr; 340(13):1021-30. PubMed ID: 10099145
    [No Abstract]   [Full Text] [Related]  

  • 17. Hematology clinic. Sickle cell disease.
    Ngo D; Steinberg M
    Hematology; 2014 Jun; 19(4):244-5. PubMed ID: 24666152
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenesis and treatment of sickle cell disease.
    Bunn HF
    N Engl J Med; 1997 Sep; 337(11):762-9. PubMed ID: 9287233
    [No Abstract]   [Full Text] [Related]  

  • 19. Sickle cell disease.
    McCavit TL
    Pediatr Rev; 2012 May; 33(5):195-204; quiz 205-6. PubMed ID: 22550263
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term use of hydroxyurea for sickle cell anemia.
    Hagar W
    JAMA; 2003 Aug; 290(6):753; author reply 754. PubMed ID: 12915424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.